Aprepitant (Emend)

aprepitant · Merck & Co.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Aprepitant (Emend), covering 2015-01-19 to 2016-06-03. Get the full timeline:

Most recent: Clinical Trial Update: Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals. 375 mg Dose [Phase 1]